Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial)
Volume
31
Pagination
1240 - 1243
DOI
10.1038/leu.2017.47
Journal
LEUKEMIA
Issue
ISSN
0887-6924
Metadata
Show full item recordAuthors
Chanan-Khan, A; Egyed, M; Robak, T; Martinelli de Oliveira, FA; Echeveste, MA; Dolan, S; Desjardins, P; Blonski, JZ; Mei, J; Golany, NURI
https://www.nature.com/articles/leu201747.pdfhttp://qmro.qmul.ac.uk/xmlui/handle/123456789/35464
